224 related articles for article (PubMed ID: 21085060)
21. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up).
Roberti I; Reisman L; Lieberman KV; Burrows L
Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548
[TBL] [Abstract][Full Text] [Related]
22. Short- and long-term cyclosporine dosage in liver transplantation.
McCaughan GW; Bookallil MJ; Sheil AG
Transplant Proc; 1994 Oct; 26(5):2674-5. PubMed ID: 7940837
[No Abstract] [Full Text] [Related]
23. Long-term follow-up of donor chimerism and tolerance after human liver transplantation.
Ayala R; Grande S; Albizua E; Crooke A; Meneu JC; Moreno A; Pérez B; Gilsanz F; Moreno E; Martínez-Lopez J
Liver Transpl; 2009 Jun; 15(6):581-91. PubMed ID: 19479801
[TBL] [Abstract][Full Text] [Related]
24. Monitoring the operationally tolerant liver allograft recipient.
Castellaneta A; Thomson AW; Nayyar N; de Vera M; Mazariegos GV
Curr Opin Organ Transplant; 2010 Feb; 15(1):28-34. PubMed ID: 19890211
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporine A withdrawal during follow-up after pediatric liver transplantation.
Scheenstra R; Torringa ML; Waalkens HJ; Middelveld EH; Peeters PM; Slooff MJ; Gouw AS; Verkade HJ; Bijleveld CM
Liver Transpl; 2006 Feb; 12(2):240-6. PubMed ID: 16447209
[TBL] [Abstract][Full Text] [Related]
26. Tolerance after liver transplantation: Where are we?
Feng S; Bucuvalas J
Liver Transpl; 2017 Dec; 23(12):1601-1614. PubMed ID: 28834221
[TBL] [Abstract][Full Text] [Related]
27. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
Charlton M; Seaberg E
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
[TBL] [Abstract][Full Text] [Related]
28. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
29. Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation.
Ashton-Chess J; Giral M; Brouard S; Soulillou JP
Transplantation; 2007 Nov; 84(10):1215-9. PubMed ID: 18049104
[TBL] [Abstract][Full Text] [Related]
30. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
[TBL] [Abstract][Full Text] [Related]
31. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
32. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
[TBL] [Abstract][Full Text] [Related]
33. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
Bahra M; Neumann UP; Jacob D; Langrehr JM; Neuhaus P
Transplant Proc; 2005 May; 37(4):1700-2. PubMed ID: 15919436
[TBL] [Abstract][Full Text] [Related]
34. Corticosteroid elimination in simultaneous liver-kidney transplantation recipients.
Weber NK; Wiseman AC; Trotter JF
Clin Transplant; 2009; 23(6):958-63. PubMed ID: 19664017
[TBL] [Abstract][Full Text] [Related]
35. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
Millis JM; Bruce DS; Newell KA; Piper JB; Woodle ES; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR
Transplant Proc; 1996 Apr; 28(2):1014. PubMed ID: 8623213
[No Abstract] [Full Text] [Related]
36. Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective.
Demetris AJ; Lunz JG; Randhawa P; Wu T; Nalesnik M; Thomson AW
Transpl Int; 2009 Jan; 22(1):120-41. PubMed ID: 18980624
[TBL] [Abstract][Full Text] [Related]
37. Low-dose tacrolimus/sirolimus and steroid withdrawal in heart recipients is highly efficacious.
Meiser B; Kaczmarek I; Mueller M; Groetzner J; Weis M; Knez A; Stempfle HU; Klauss V; Schmoeckel M; Reichart B; Ueberfuhr P
J Heart Lung Transplant; 2007 Jun; 26(6):598-603. PubMed ID: 17543783
[TBL] [Abstract][Full Text] [Related]
38. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
[TBL] [Abstract][Full Text] [Related]
39. Successful withdrawal of corticosteroids in heart transplantation.
Miller LW; Wolford T; McBride LR; Peigh P; Pennington DG
J Heart Lung Transplant; 1992; 11(2 Pt 2):431-4. PubMed ID: 1571342
[TBL] [Abstract][Full Text] [Related]
40. What can we learn from the transcriptional characterization of spontaneously tolerant transplant recipients?
Danger R; Racapé M; Soulillou JP; Brouard S
Curr Opin Organ Transplant; 2010 Aug; 15(4):435-40. PubMed ID: 20616726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
